openai ceo semaglutide experience Sam Altman biographer Keach Hagey explains why the was 'born for this moment' The Future According to OpenAI's

Have you ever witnessed a patient in hypovolemic shock

PPG postprandial glucose, FPG fasting plasma glucose, HbA1c glycated hemoglobin A1c Recent studies seem to suggest better outcomes with insulin analogues

The pill formulation provides a convenient alternative to injectable therapies and was commercially launched in the United States in early 2026, expanding treatment accessibility in the rapidly growing obesity and metabolic disease therapeutics market

That said, I think its important to remember that clinical practice often includes thoughtful, evidence-informed use of therapies outside of formal trial dosing or FDA labeling, especially when its legal and guided by sound clinical judgment